Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CNSP
#5159
CNS Pharmaceuticals, Inc. Common Stock
2.6
4
USD
+8.64%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+8.64%
Monthly Change
+5.60%
6 month change
-72.36%
Year Change
+120.00%
Previous Close
2.4
3
Open
2.6
4
Bid
Ask
Low
2.6
4
High
2.6
4
Volume
1
Markets
US Stock Market
Healthcare
CNSP
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
28.11
44.48
74.21
354.5
245.37 K
811.45 K
—
Valuation ratios
Enterprise value
31.44 M
23.5 M
-3.72 M
12.41 M
11.59 M
-2.61 M
-18.59 M
Price to earnings ratio
—
—
-0.24
-0.24
-0.15
-0.15
-0.14
Price to sales ratio
—
—
-1 164.33
164.89
12.11 K
-909.61
—
Price to cash flow ratio
—
—
-0.34
-0.32
-0.13
-0.17
-0.24
Price to book ratio
—
—
0.45
-1.01
0.37
0.51
0.57
Enterprise value to EBITDA ratio
-3.38
-1.71
0.21
-0.64
-0.76
0.18
1.28
Profitability ratios
Return on assets %
-0.6
-1.6
-1.17
-11.08
-1.71
-1.84
-1.44
Return on equity %
-0.68
-2.12
-1.88
4.25
-2.41
-3.5
-2.21
Return on invested capital %
-6 290.05
-4 005
-4 206.49
-11.53 K
-15.3 K
-10.5 K
—
Gross margin %
100
—
100
100
100
100
—
Operating margin %
597.26 K
—
490.75 K
-69.39 K
-7.84 M
624.72 K
—
EBITDA margin %
596.66 K
—
490.47 K
-69.27 K
-7.84 M
624.67 K
—
Net margin %
597.47 K
—
490.97 K
-69.33 K
-7.82 M
619.4 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.13
3.5
2.55
0.26
3.43
1.98
22.95
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
-0
0
-0
0
0
-0
-0
Solvency ratios
Debt to assets ratio
0.03
0.04
0.03
0.18
0.04
0.04
0.06
Debt to equity ratio
0.03
0.06
0.05
-0.07
0.05
0.07
0.1
Long term debt to total assets ratio
0.03
0.04
0.03
0.18
0.04
0.04
0.06
Long term debt to total equity ratio
0.03
0.06
0.05
-0.07
0.05
0.07
0.1
Per share metrics
Operating cash flow per share
—
—
-232.6 K
-112.6 K
-537.25
-31.15
-39.48
EBIT per share
—
—
-336.41 K
-150.01 K
-467.82
-36.06
-44.93
EBITDA per share
—
—
-336.15 K
-149.98 K
-467.72
-36.05
-44.92
Total debt per share
—
—
9 031.88
2 395.35
10.24
0.74
2.05
Cash per share
—
—
221.53 K
4 369.53
202.85
16.24
124.09
Net current asset value per share
—
—
276.81 K
12.67 K
271.82
18.28
137.25
Tangible book value per share
—
—
179.17 K
-35.29 K
193.91
10.2
111.67
Working capital per share
—
—
168.41 K
-36.17 K
192.58
9.03
108.52
Book value per share
—
—
179.17 K
-35.29 K
193.91
10.2
111.67
News
CNS Pharmaceuticals shifts focus to neurology, oncology assets
CNS Pharmaceuticals names Lynne Kelley as chief medical officer
CNS Pharmaceuticals appoints three new executives to leadership team
CNS Pharmaceuticals’ new CEO outlines strategic overhaul
Corero Network Security reports DDoS protection platform enhancements
CNS Pharmaceuticals stock falls after CEO steps down
CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco
CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting
CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript
Corero Network Security reports Q3 order intake growth
Upcoming Stock Splits This Week (July 21 to July 25) – Stay Invested - TipRanks.com
CNS Pharmaceuticals announces 1-for-12 reverse stock split